Navigation Links
Vermillion Reports Financial Results for the First Quarter 2011
Date:5/10/2011

Total assets

$
40,907$
24,035Liabilities and Stockholders’ EquityCurrent liabilities:Accounts payable

$
,132$
998Accrued liabilities

3,2343,056Convertible senior notes

5,0005,000Deferred revenue

9331,049Total current liabilities

10,29910,103Long-term debt owed to related party

7,0007,000Warrant liability

71378Deferred revenue

1,5651,679Other liabilities

208259Total liabilities

19,14319,419Commitments and contingenciesStockholders’ equity:Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding at March 31, 2011  and December 31, 2010, respectively

--Common stock, $0.001 par value, 150,000,000 shares authorized at March 31, 2011 and December 31, 2010; 14,698,509 and 10,657,564 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively

1511Additional paid-in capital

324,706303,270Accumulated deficit

(302,800)(298,509)Accumulated other comprehensive loss

(157)(156)Total stockholders’ equity

21,7644,616Total liabilities and stockholders’ equity

$
40,907$
24,035Vermillion, Inc.Consolidated Statement of Operations(Amounts in Thousands, Except Share and Per Share Amounts)

(Unaudited)Three Months Ended March 31, 20112010Revenue:Product

$
317$
-License

11473Total revenue

43173Cost of revenue:Product

42-Total cost of revenue

42-Gross profit

38973Operating expenses:Research and development(1)

1,218748Sales and marketing(2)

1,318193General and administrative(3)

2,3002,136Total operating expenses

4,8363,077Loss from operations

(4,447)(3,004)Interest income

166Interest expense

(115)(143)Change in fair value and gain from exercise of warrants, net

307(6)Debt conversion costs

-(141)Reorganization items

(16)
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Vermillion Receives Award From the Society of Gynecologic Oncologists
2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
4. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
5. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
6. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
7. Vermillion Announces the Reappointment of Officers and Confirmation of Director
8. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
9. Vermillion Announces $43.05 Million Private Placement of Common Stock
10. Vermillion Files Plan of Reorganization
11. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 27, 2015 ... 2014 market research report to its store. This ... Ulcers, therapeutic pipeline. The report "Corneal ... the therapeutic development for Corneal Ulcers. Corneal Ulcers ... includes bacterial infections, viral infections & fungal infections. ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
(Date:2/26/2015)... 26, 2015 Every year many millions of ... heart disease.  Nevertheless, year after year doctors and the ... the first test to determine the status of heart ... or not, even though that technology is over 100 ... that doctors know, (while most patients do not know) ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2
... Expands Enterprise Intelligence Systems to Healthcare Market, ... Booth #1841 --,Harris Corporation (NYSE: HRS ... has joined forces with Cancer Treatment,Services International ... of,radiation oncology. Harris will provide advanced imaging ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... novel drugs for the treatment of,diabetes, obesity ... has,initiated a Phase 2b study in diabetic ... non-TZD SPPARM (Selective Peroxisome,Proliferator-Activated Receptor Modulator). INT131 ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2
(Date:2/26/2015)... 2015 Dr. Parsa Mohebi, a world-renowned hair ... contest winner’s surgery on Friday, February 27, 2015. ... is all set to receive his grand prize of 2000 ... procedure will be done on a live feed which will ... surgery, go to the website and experience everything from the ...
(Date:2/26/2015)... 26, 2015 PartnerTech Inc . has ... Makers Awards finalist. , The Movers & ... in the manufacturing, processing, or distribution of tangible products and ... This annual event serves as Georgia’s largest local awards ... to draw more than 300 local industry and business leaders. ...
(Date:2/26/2015)... In a nested-case control study of individuals ... a relatively low incidence of liver cancer, statin use is ... to a new study published February 26 in the ... studies have reported this association but most used data from ... rate, such as Asia. Katherine A. McGlynn, Ph.D., from the ...
(Date:2/26/2015)... 2015 marks five years of being ... Caggiano! , Orthodontics is a perfect blend of ... background in biomedical engineering, his artistic talent, his extensive ... dentist allows Dr. Caggiano to create innovative approaches to ... named Orthodontic Products’ Best of 2012, a national recognition, ...
(Date:2/26/2015)... February 26, 2015 Beckman Coulter is ... extracellular vesicles and their cargo in cell-to-cell communication,” which ... their relevance for cell-to-cell communication. The webinar is free ... 2015 at 8:00am PT. , Every cell in the ... (EVs) , often called “exosomes” or “microvesicles.” These vesicles ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... , DALLAS, Oct. 27 /PRNewswire-FirstCall/ -- Zix Corporation ... for email encryption and payor-sponsored e-prescribing, today announced financial results ... recorded third quarter revenues of $7.8 million and a GAAP ... loss per share, compared with revenues of $6.7 million, and ...
... Inc. (Nasdaq: AMCS ), a leader in image ... will report the company,s financial results for the third ... on Tuesday, November 3, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ... its financial results, management will host a conference call ...
... Calif., Oct. 27 The Ensign Group, Inc. (Nasdaq: ... group of skilled nursing, rehabilitative care services, assisted living ... to issue its third quarter 2009 financial results following ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Conference Call ...
... change, in testing methods in a few years , TUESDAY, ... newer liquid-based cytology are equally reliable in screening for cervical ... States, liquid-based cytology testing has all but replaced the traditional ... method is best, according to Dr. Mark Schiffman, a senior ...
... benefit, study finds , TUESDAY, Oct. 27 (HealthDay News) ... depression offers substantial benefits at moderate cost, U.S. researchers ... assigned to one of three types of care for ... included five outreach calls for monitoring, support, feedback and ...
... Highmark Inc. was recognized as one ... 2009 Well Workplace Award for its commitment to protecting ... As the state,s largest health insurer, Highmark provides its ... "At Highmark, wellness isn,t something we just discuss, it,s ...
Cached Medicine News:Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 2Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 3Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 4Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 5Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 6Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 7Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 8Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 9Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 10Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 11Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 12Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 13Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 14Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 15Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 16Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 17Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 18Health News:Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results 19Health News:AMICAS Schedules Third Quarter 2009 Earnings Results Conference Call 2Health News:The Ensign Group Schedules Third Quarter 2009 Earnings Call for Tuesday, November 3, 2009 2Health News:Old, New Pap Methods Equally Good, Dutch Study Finds 2Health News:Old, New Pap Methods Equally Good, Dutch Study Finds 3Health News:Phone Counseling for Depression Rings With Promise 2Health News:Highmark Recognized as One of America's Healthiest Companies 2
... is the most potent, naturally secreted estrogen ... the ovary [1]. In the ovary, estradiol ... estrone, a less potent estrogen derived from ... many body tissues. In men, small amounts ...
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum....
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
Medicine Products: